Predictors of Intracranial Hemorrhage in ARDS Patients on ECMO
NCT ID: NCT04142775
Last Updated: 2019-10-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2019-02-01
2020-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Prognostic Factors in Patients Admitted to ICU for Stroke
NCT04434287
Hemostatic Disorders on Intensive Care Patients.
NCT04179357
Coagulation Monitoring in Patients on Extracorporeal Membrane Oxygenation (Observational Study)
NCT03642912
Coagulopathy and SIRS During ECC in Intensive Care
NCT02352805
Severe Hypoxemia : Prevalence, Treatment and Outcome
NCT02722031
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intracranial hemorrhage (ICH)
ARDS patients treated with ECMO developing ICH
complication versus no complication
development of ICH
no intracranial hemorrhage
ARDS patients treated with ECMO not developing ICH
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
complication versus no complication
development of ICH
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ECMO therapy (veno-venous cannulation)
Exclusion Criteria
* ICH at initiation of ECMO
* no cerebral CT scan at any time
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mario Menk
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charite university medicine Berlin
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ChariteMM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.